Stockscreener 앱 받기
2.17
5.65%
-0.13
Century Therapeutics Inc 주식(IPSC)의 최신 뉴스
Brokerages Set Century Therapeutics, Inc. (NASDAQ:IPSC) PT at $3.40 - Defense World
Century Therapeutics, Inc Updates on Pipeline and Clinical Progress - TradingView — Track All Markets
Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Century Therapeutics (NASDAQ:IPSC) Upgraded at Zacks Research - Defense World
Century Therapeutics: Is This Stem Cell Stock Taking Root In 2026? - RTTNews
Is Century Therapeutics Inc. stock supported by strong cash flowsWeekly Trading Summary & Free Technical Pattern Based Buy Signals - Улправда
Can Century Therapeutics Inc. stock outperform in 2025 bull marketMarket Performance Summary & Expert Verified Stock Movement Alerts - ulpravda.ru
Century Therapeutics Inc. (IPSC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How strong is Century Therapeutics Inc. stock revenue growthOil Prices & Stepwise Swing Trade Plans - ulpravda.ru
Can Century Therapeutics Inc. stock surprise with earnings upsidePortfolio Return Summary & AI Forecasted Stock Moves - Улправда
Century Therapeutics Inc.: Is an Upswing Approaching? - StocksToTrade
Century Therapeutics wins $135M private placement (IPSC:NASDAQ) - Seeking Alpha
Will Century Therapeutics Inc. stock deliver better than expected guidanceEarnings Growth Summary & Trade Opportunity Analysis Reports - Улправда
Can Century Therapeutics Inc. stock reach $100 price target2025 Geopolitical Influence & Safe Swing Trade Setups - ulpravda.ru
Century Therapeutics stock price target lowered to $6.60 at Clear Street - Investing.com Canada
Is Century Therapeutics Inc. stock attractive after correctionJuly 2025 PreEarnings & Consistent Growth Stock Picks - Улправда
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Aug Swings: What sentiment indicators say about Century Therapeutics Inc. stockTrend Reversal & Daily Chart Pattern Signals - Улправда
Why Century Therapeutics Inc. stock is rated strong buyTrade Entry Report & Weekly Market Pulse Updates - Улправда
Will Century Therapeutics Inc. stock deliver long term returnsAnalyst Downgrade & Long Hold Capital Preservation Plans - Улправда
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes - Investing News Network
Century Therapeutics: New Leadership Sparks Interest - timothysykes.com
Layoff Watch: Is Century Therapeutics Inc. stock attractive for income investors2025 Risk Factors & Verified Short-Term Plans - ulpravda.ru
Century Therapeutics secures $135 million in private placement By Investing.com - Investing.com India
Century Therapeutics secures oversubscribed $135 million private placement financing to support lead program, CNTY-813 - marketscreener.com
Century Therapeutics secures $135 million in private placement - Investing.com
Century Therapeutics Signs Multiple Financing Agreements - TradingView — Track All Markets
[8-K] Century Therapeutics, Inc. Reports Material Event | IPSC SEC FilingForm 8-K - Stock Titan
Big bet on type 1 diabetes: $135M backs potentially curative cell therapy - Stock Titan
Zacks Research Upgrades Century Therapeutics (NASDAQ:IPSC) to Strong-Buy - MarketBeat
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain - sharewise.com
Century Therapeutics, Inc.Common Stock (NQ: IPSC - FinancialContent
Century Therapeutics (IPSC) price target decreased by 20.00% to 4.08 - MSN
Dow Theory LettersCentury Therapeutics, Inc.Common Stock (Nasdaq:IPSC) Detailed Stock Data - FinancialContent
Critical Analysis: EOM Pharmaceutical (OTCMKTS:IMUC) & Century Therapeutics (NASDAQ:IPSC) - Defense World
Why fast-paced mover Century Therapeutics (IPSC) is a great choice for value investors - MSN
Trend Report: Is Century Therapeutics Inc stock attractive after correctionJuly 2025 Update & Expert-Curated Trade Recommendations - moha.gov.vn
Street Watch: Why Century Therapeutics Inc stock is rated strong buyJuly 2025 Macro Moves & Safe Entry Trade Reports - moha.gov.vn
Chad Cowan Buys 58,060 Shares of Century Therapeutics (NASDAQ:IPSC) Stock - MarketBeat
Century Therapeutics announces resignation of board member - TipRanks
Century Therapeutics Announces Board Resignation - TradingView — Track All Markets
Century Therapeutics, Inc. Announces Resignation of Carlo Rizzuto as Director., Effective December 18, 2025 - marketscreener.com
Century Therapeutics (IPSC) announces board resignation of Carlo Rizzuto - Stock Titan
Century Therapeutics Unveils iPSC Beta Islet Program as Cash Runway Extends Into 2027 - MSN
Century Therapeutics, Inc. (NASDAQ:IPSC) Sees Significant Decrease in Short Interest - MarketBeat
Century Therapeutics to Showcase Promising Cell Therapy Data at ASGCT Annual Meeting - MSN
Would You Still Hold Century Therapeutics Stock If It Fell 30%? - Trefis
What sentiment indicators say about Century Therapeutics Inc. stockJuly 2025 Review & Fast Entry Momentum Alerts - DonanımHaber
Will Century Therapeutics Inc. stock benefit from infrastructure spendingStop Loss & Advanced Technical Signal Analysis - DonanımHaber
Century Therapeutics adds veteran deal-makers to board as pipeline nears clinic - MSN
Why Century Therapeutics Inc. stock is popular among millennialsRisk Management & Target Return Focused Stock Picks - DonanımHaber
There's No Escaping Century Therapeutics, Inc.'s (NASDAQ:IPSC) Muted Revenues Despite A 32% Share Price Rise - simplywall.st
Brent Pfeiffenberger Purchases 52,000 Shares of Century Therapeutics (NASDAQ:IPSC) Stock - MarketBeat
Century Therapeutics CEO Brent Pfeiffenberger Acquires 52,000 Shares - TradingView — Track All Markets
Century Therapeutics (IPSC) CEO and director reports 52,000-share buy - Stock Titan
4.73%
0.92%
자본화:
|
볼륨(24시간):